MET and ovarian carcinoma: Expression of HER family members, c-MET, IGF-IR and CD44 determined by immunohistochemistry in FIGO stage III and IV ovarian cancer patients, data are presented based on the percentage of tumour cells with positive staining, the intensity of staining and the cellular location of staining